Saturday, February 06, 2021 1:39:35 PM
is what they are.
The VYST Security Details information, easily found at OTC Markets,
shows that the O/S has been raised every single time it is updated.
I have saved screen shots of each update dating back to October 2020
(didn't think of it before then)
and last October the O/S was 1,159,986,315
The most recent update Feb 2nd shows O/S 1,222,669,662
So Vystar has added 62,683,347 shares to the O/S
In less than 4 months! Over 62 Million shares.
VYST stock diluted every single update!
Wanna talk about the supposed share buy back
when Vystar instead DUMPED 600 MILLION shares??
That Vystar LIE never fails to get a few chuckles!
On top of that, Vystar has been using shares of VYST as a piggy bank for as long as the Rotman's have been running the show.
Some excellent examples of this are clearly stated -
using actual facts copied straight from Vystar financial filings
on my sticky post above -
Wanna talk about Stock Dilution? ooookay ...!!
Don't forget to read up on the other usage of Vyst stock in
this other sticky post. It's such fun reading!
Today's FUN Vystar FACTS!! (get a strong drink)
yeah.... everything is done for the shareholders that Vystar loves so dearly! (sarc.)
Nothing but FACTS here.
Recent VYST News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 08:06:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 11:01:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:21:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 07:36:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:46:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:41:50 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/10/2023 09:14:55 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM